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1. Introduction
Pharmacology is the science that studies the physiological and biological effects of exogenous
substances which are not part of the internal milieu of a living organism whether natural or
synthetic termed xenobiotics (drugs, chemicals) on the cells, tissues, or organs of the organ‐
isms. There are many specialized areas of pharmacology and these include clinical pharma‐
cology; which deals with the application of pharmacological principles and methods in the
medical clinic with the focus on patient care and outcomes, neuro-pharmacology; which deals
with effects of medication on central and peripheral nervous system function, psycho-
pharmacology; which observes the effect of medication on the changed behaviours of the mind
and body and how molecular events are manifested in a measurable behaviourable form. Other
areas are pharmacodynamics; the chemical effect on the body, pharmacogenetics; the genetic
variation that gives rise to differing response to drug, and the related area of pharmacoge‐
nomics, which is the application of genome technologies and the influence of the whole human
genome on drug response, toxicology; which studies the harmful effect of drugs or chemicals
and their molecular targets and characterization, pharmacognosy; the study of medicinal
substances of biological origin, pharmacokinetics; that deals with the effect of the body on
chemical half life and lastly environmental pharmacology which can be defined as the effect
of pharmaceuticals and house care products on the environment and the ecosystem (Halling-
Sorensen et al 1998). Environmental pharmacology is a relatively new and emerging specialty
of pharmacology. It involves the study of gene-environment interaction, drug-environment
interaction and toxin-environment interaction. It is important to emphasize at this stage that
the different terms used interchangeable with environmental pharmacology include ecophar‐
macology, and pharmacoenvironmentology, ecotoxicology. However, a close similarity exists
between environmental pharmacology and ecotoxicology. Environmental pharmacology
entails the study of environmental science, medicine, ecology, genetics and chemistry.
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The impact of pharmaceuticals on the ecosystem has significance public health implications.
The demand for more pharmaceuticals relative to world’s population growth may place the
public at risk though the destruction of species. The entry of chemicals and drugs into the
aquatic ecosystem is of a serious concern and empirical evidences are making these concerns
more compelling. In addition, the production of illegal drugs pollutes drinking waters supply
by releasing possible carcinogens (Ruhoy and Daughton 2008). All these factors necessitate the
need for substances that are more biodegradable for the manufacture of drugs by pharma‐
ceutical companies. However, environmental contamination by drugs may or may not lead to
toxic effect on the ecosystem but usually there can be modifying effects. (Daughton and Ternes
1999)
1.1. Historical perspectives
In recent years, human pharmaceuticals from numerous therapeutic classes have increasingly
been detected in the environment, typically at ng/l to low µg/l in surface water (Holm et al
2008). Another notable observation was the traces of narcotics like cocaine in River Thames
(Goswani and Orr 2005). In addition, illegal cultivation of marijuana in bushes close to surface
water with potential effect on the ecosystem is also a source of concern. The observation in
1997 of the decline in the population of the Asian white- backed vulture (Gyp) and the Indian
vulture nesting in Keoladeo Natural Park in North Western India prompted the Indian
Government to ban the drug ‘diclofenac’. The vulture population drastically reduced over the
years from 150 in 1997 to 25 in 2010. It was observed that they die after feeding on cattle treated
with diclofenac. Diclofenac sodium is a non steroidal anti -inflammatory (NSAID) pain killer
used by veterinary doctors to treat cattle. Because of lack of proper detoxification pathway for
diclofenac in vultures, it’s ingestion leads to visceral gout and subsequent renal failure and
death when they feed on the carcasses of animals treated with the drug (Oaks et al 2004).An
alarming decline in the number of vultures poses the threat of outbreak of epidemics because
of increase in the population of undecayed carcasses and feral dogs which pose a range of
disease threats such as rabies in India (Brakash et al 2003).
Effects of some drugs on aquatic organisms have been investigated in acute toxicity assays
However, the chronic toxicity and potential subtle effects are only marginally known (Fent et
al 2006). Environmental contamination by pharmaceuticals is not restricted to developing
countries but it is a worldwide phenomenon. This underscores the importance of this emerging
field of pharmacology. A study in the United States by the Geological Survey Department
found traces of many different drugs and personal care products including steroids, insect
repellants and phthalates in the American water supply. Although the concentrations were in
traces, the effect of chronic exposure can be unpredictable (Palla va Bagla 2004). The production
of bulk drugs has also been recently identified as an important source for environmental
pollution with active pharmaceutical ingredients in certain locations (Gunnarson et al 2009,
Fick et al 2010).A growing number of pharmaceutical residues are also found in surface water
worldwide, raising concerns about their effects on the aquatic organism and posing a major
challenge to developing rational strategy for prioritizing drugs on which to focus the most
extensive environmental research efforts (Fick et al 2010). Traces of drug residues may pose
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risk to aquatic life as depicted by various studies (Daughton and Terres 1997, Cleavers 2003,
Boxall et al 2004, Kidd et al 2007). There is equally concern to human health sequel to the
exposure to contaminated drinking water (Daughton 2004, 2008).
2. Sources and fate of pharmaceutical and house care products in the
environment
The potential routes of entry of pharmaceutical and house hold care products in the environ‐
ment include :
i. patients’ excretion either as a parent compound or metabolites, via the sewer system
ii. direct release into the waste water system from manufacturing, hospitals or disposed
via toilets and sinks
iii. terrestrial depositions for example via sludge application to land, leaching from solid
waste landfills or irrigation with treated and untreated waste water. It is generally
accepted that excretion of pharmaceuticals after human and veterinary therapeutic
use dominates the global input of pharmaceuticals into the environment. Manufac‐
turing effluent discharges and the disposal of unused drugs make a relatively small
contribution to the overall environmental drug load. In addition, localized increased
concentrations of drugs can occur adjacent to discharges from hospitals.
iv. Non pharmaceutical industrial sources, for example plastic products manufacturers
are potential sources for the release of bisphenol A; used in the manufacturing process
and known to have pharmacological effects on man and aquatic animals. Another
pollutant from many household products is phthalates.
v. Overflow of agricultural run off may contain herbicides, pesticides and fertilizers and
pose a potential danger to the ecosystem.
vi. Aging infrastructure also promotes the release of pharmaceuticals to the environ‐
ment. Even when waste water makes it to sewage treatment facilities, they are not
equipped to remove pharmaceuticals. As a result, our steams and rivers are exposed
to a cocktail of synthetic compounds from stimulants and antibiotics to analgesics
and anti histamines.
vii. Another important source of pharmaceuticals in the environment are drugs destined
for plant health. For example, plant parasitic nematodes cause global crop losses of
about $125billion annually. Current chemicals used to control these pests have been
withdrawn due to their environmental toxicity. This necessitated companies like
Bayer Crop Science to reinforce research in this respect in order to come up with a
suitable and safer alternative product.
viii. There has been little consideration for herbal preparations and their interaction with
the environment, since they possess pharmacological properties. A recent example
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can be found in aristolochic acid, a carcinogen, mutagen and nephrotoxin commonly
found in Aristolochiacea family of plants including Aristolochia (Birthworth) and
Asarum (wild ginger) which are commonly used in Chinese herbal medicine
(Barceloux 2008, Henrich et al 2009,Gluhovschi et al 2011). Aristolochic acid I is the
most abundant of the aristolochic acids and it is found in almost all aristolochia
species. Aristolochic acids are often accompanied by arisolactams which has been
implicated as the causative agent of Balkan endemic nephropathy, Chinese herbs
nephropathy and urothelial cancer.
2.1. Pharmaceutical active compounds (PhACs)
Pharmaceutical active compounds (PhACs) are those pharmaceuticals that have by one route
or another entered the environment as the parent compound or as pharmacologically active
metabolites. For many years, PhACs was not given any meaningful attention due to the fact
that environmental researchers concentrated on the well known environmentally dangerous
chemicals that are largely used in agriculture and industry. PhACs have not until recently been
seen as potentially toxic because regulations associated with pharmaceuticals are typically
overseen by drug related organizations which have limited experience with environmental
issues (Jones et al 2001).
The list of common PhACs found in the environment includes
i. Analgesics with anti inflammatory and anti pyretic capabilities viz acataminophine,
acetylsalicylic acid, diclofenac, codein and Ibuprofen
ii. Antibiotics: macrolide antibiotics, sulfonamide fluoroquinolones, chloramphenicol,
tylosin, trimethoprin, erythromycin, lincomycin, sulfamethoxazole and trimetho‐
prin.
iii. Anticonvulsant: carbamazepine, primidone.
iv. Beta – blockers: metoprolol, propanolol, betaxolol, bisoprolol, nadolol
v. X ray media: 10 promide, 10 pamidol, 10 hexol and diatrizoate.
vi. Steroid and hormonal preparation: 17 α ethinyl estradiol, mestrennol and 19-
noresthisterone
vii. Miscellanous: household products, pesticides veterinary drugs and insecticides.
2.1.1. Fate in the environment
Once PhACs enters the environment, they suffer one of three fates which include:
i. Biodegradation into carbon dioxide and water
ii. Undergo some form of degradation to form metabolites
iii. Persist in the environment unmodified. The amount of the compound that is broken
down depends on several factors such as bioavailability and compound structure
among others.
Pharmacology and Therapeutics136
2.2. Biodegradation of xenobiotics
Biodegradation is the complete breakdown of the complex and toxic contaminates to non-toxic
simple elements by the action of microbes. Hence, these contaminants act as the microbial food
substrate. Biodegradation, in general can be considered as a series of steps of biological
degradation or pathway that ultimately result in the oxidation of the compound which most
often results in the generation of energy while xenobiotics in the human body are removed by
a process called xenobiotic metabolism, in which these compounds are degraded by the liver
enzymes such as Cytochrome P450 which activate the xenobiotics by the process of oxidation,
or hydration, reduction or hydration followed by conjugation with glucuronic acid, sulphuric
acid or glutathione, and the compound conjugates are excreted by urination, exhalation,
sweating and defeacation. The xenobiotics in the environment are degraded by the microbes.
Microbes have the capacity to degrade all naturally occurring compounds by the principle of
microbial infallibility proposed by Alexander in 1985. Microbes can degrade many of the
xenobiotic compounds, but not all. The compounds that resist biodegradation and persist in
the environment are called “recalcitrant or Environmental persistent pharmaceutical pollu‐
tants (EPPP).
For complete biodegradation, oxidation of parent compound occurs to form carbon dioxide
and water. Each step in the degradation pathway is catalyzed by a specific enzyme produced
by the degrading cell. Degradation of some xenobiotics depends on the presence of a specific
compound, which includes the required enzymes. These enzymes are metabolized to provide
both energy and reducing equivalent for the degradation of xenobiotics compounds. Example
of such enzymes are the oxygenases; a group of enzymes that catalyses the reactions that
transforms the hydrophobic nature of the organic compound to water soluble forms which
can be broken down by a larger number of other micro organisms. The oxygenases are of two
main classes; mono-oxygenases and dioxygenases. These enzymes participate in the oxidative
metabolism of a wide variety of chemicals of pharmaceutical, agricultural and environmental
significance. Some of the most widely recognized substrate for this class of enzymes are the
aliphatic and aromatic hydrocarbons of both endobiotic and xenobiotic sources. Monoxyge‐
nases are a class of enzymes that insert one atom of the oxygen molecule into the substrate;
the other atom becomes reduced to water. They are also more complex and can catalyze several
different types of oxygen atom insertion reactions. Since they can oxidize more than one
substrate, they are called mixed functions oxidizers or oxidases. Also, since one of the main
substrates gets hydrolysed they are also called hydroxylases. The general stoichiometry of the
is reaction is as follows:
R-H + NAD (P)H + 02 → R – OH +NAD (P) + H20
Dioxygenases incorporate both atoms of the oxygen molecule into substrate and are crucial in
initiating the decomposition of a variety of chlorinated and nitro-aromatic compounds as well
as non-substituted polycyclic aromatic hydrocarbons. Many of these compounds are first
degraded to catechol protocatechuate by oxygenases (dioxygenases and monoxygenases).The
intermediates are metabolized by ring cleavage type of dioxygenases to either beta-keto
adipate or 2keto-4-hydroxy valerate. These intermediates then enter the TCA cycle. When the
organism evolves to start tolerating the xenobiotic compound, it can lead to the phenomenon
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called ‘resistance’. An example is the resistance of the bacteria to certain antibiotics. In addition,
some of these substances are resistant to degredation, for example plastics and certain
pesticides. However it is understood that microbes have the ability to degrade many of these
recalcitrant compounds.
2.2.1. Environmental Pharmaceutical Persistent Pollutants (EPPP)
The term Environmental Pharmaceutical Persistent Pollutants (EPPP) was suggested in the
nomination 2010 of Pharmaceutical and Environment as an emerging issue to Strategic
Approach to International Chemical Management (SAICM) by the International Society of
Doctors for the Environment (ISDE). Pharmaceuticals are synthetic chemicals belonging to a
wide group of different chemical families and may also react differently in the environment.
There are documented evidences that some pharmaceuticals enter and persist in the environ‐
ment. (Ruhoy and Daughton 2008, Segura et al 2005) Some are endocrine disruptors, particu‐
larly the synthetic hormones (Fick 2009, Snyder et al 2003) some are designed to kill bacteria
and viruses and may affect microorganisms and wild life in severe and unexpected ways
( Segura et al 2005). Little is known about the possible negative effects and impacts of EPPP in
humans and the environment by diffuse and systematic exposure for long periods of time
especially during the vulnerable periods of development. As there are thousands of different
synthesized chemicals present at the same time in the environment, different interactions may
occur and the result of these multiple exposure in human and nature are not sufficiently
studied or understood. EPP’s are already found in water all over the world. The diffuse
exposure might contribute to:
i. Extinction of species and imbalance of sensible ecosystems ; since many EPPS affect
the reproductive systems of for example frogs, fish and mussels.
ii. Genetic, developmental, immune and hormonal health effects to humans and other
species in the same way as oestrogen- like chemicals.
iii. Development of microbes resistant to antibiotics, as is found in India.
Some pharmaceuticals are degraded to various extents in sewage treatment plants but others
leave the plant in active forms. Active residues have been detected in surface water, and they
may persist in the environment for long periods of time. Large amounts of antibiotics and other
pharmaceuticals have also been found downstream from sewage plants for pharmaceutical
industries. EPPs from sewage sludge used as fertilizes can be absorbed by soya, and antibiotics
have been found in the leaves. Many EPP’s have been detected in drinking water and these
include Atenolol (beta blocker) citalopram (anti depresseant drugs Diclofenc (analgesic)
Ibuprofen, (analgesic) metoprolol (beta blocker) Neproxen (anti inflammatory) and Trimeto‐
prin (antibiotic) have been found in drinking water of Stockholm, Sweden Fish caught
downstream from the sewage plants of Stockholm contained citalopram (antidepressant drug)
and propoxyphene (narcotic/anaesthetic) (Daughton 2008, Hernando et al 2006). Several broad
– spectrum antibiotics in very high concentrations as well as bacteria resistant to all known
antibiotics were found downstream from a sewage plant in India. Also in Indian drinking
water, cetrizine (antihistaminic) aprothoxacin (antibiotic), enoxacin (antibiotic) terbinafin
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(antimycotic) and cataboprain (anti depressant drug) were found. Furthermore, up to 14
different pharmaceuticals have been found in the drinking water of big cities around the world.
Some of these environmental pharmaceutical chemicals are well known to have serious
genotoxic effects in humans. Half life in nature varies depending on the environment (air,
water, soil, sludge) but is more than one year for several compounds (Neeman et al 2004,
Conroy et al 1999, Sevage et al 2005). Clofibric acid, a metabolite of the lipid lowering agent
clofibrate can still be found in surface as well as well-water despite the fact that clofibrate has
been withdrawn from use long ago. Concentrations of EPPs can vary from 1ng to 1mg per litre.
Serious effects of EPPPS on water living organisms especially on reproductive systems and
microbial communities have been observed (Elloriaga et al 2013, Suartz and Perez-coll 2013)
Halling- Sorensen 2007, Daughton and Hernes 1999).
3. Effect of xenobiotics on the environment and the ecosystem
More than 13 million deaths every year have been associated with environmental pollutants
and as much as 24% of diseases are estimated to be caused by environmental exposures which
can be averted. Today, detectable levels of pharmaceutical preparations either as parent drug
or metabolite are found in food stuffs, water, i.e both rivers and seas. Although the levels might
not be toxic in a single exposure, low dose chronic toxicity should be anticipated. (Jorgenson
and Halling-Sorensen 2000).The prescribing and usage of medications for both humans and
domestic animals have ramifications extending far beyond the traditional objectives of
conventional medical care. The healthcare industry has an environmental footprint that
includes the active pharmaceutical ingredients (API) from medications, residues of which can
establish themselves as environmental pollutants. Many parallels exist between healthcare and
the protection and remediation of the environment, spanning the stages from symptology and
diagnosis and treatment (Daughton and Ruhoy 2008).
3.1. Drug – environment interaction (DXE)
Drugs interact with the environment in diverse ways and these include the aquatic system,
ground water and surface water, sewage systems, flora and fauna of the ecosystems, causing
various modifications including bacterial drug resistance. (Bound and Voulvoulis 2004)
3.1.1. Aquatic system
A growing number of pharmaceuticals are found in surface waters worldwide, raising
concerns about their effects on aquatic organisms and it is major challenge to develop a rational
strategy for prioritizing drugs on which to focus the most expensive environmental research
efforts. Among aquatic organisms, fish most often share drug targets with humans. Very little
is known about the long-term effect of drugs in aquatic organisms. A study suggested that
anti- depressants like fluoxetine could trigger spawning in some shell fish (Pailla va Balga
2004), thereby disturbing the ecosystem (Jones at al 2001)
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An Indian study of effluents from industrial site in which a large number of pharmaceutical
companies send their waste water revealed the presence of pharmaceuticals in the treated
effluents. In the said study of aquatic rainbow trout (Oncorhynchus mykiss) exposed to 0.2% of
the effluent for 5 days, induction of hepatic cytochrome P450IA (CYPIA) genes expression as
well as enzyme activity were observed. In addition, clinical blood chemistry analysis revealed
an increase in plasma phosphate levels which by interpolation in humans, indicates impaired
kidney function. In addition, several oxidative stress related genes were found to be induced
in the livers, however, no significant changes were observed in antioxidant enzyme activities
or in the hepatic glutathione levels. Furthermore, estrogen-regulated genes were slightly up-
regulated following the exposure and moderate levels of estriol were detected in the effluent.
The pattern of regulated gene may contribute to the identification of mechanism of sub-lethal
toxicity as well as illuminate possible causative agent (Gunnarsson et al 2009).
Ketoprofan and diclofenac are non steroidal anti-inflammatory drugs (NSAIDS) often used
for similar indications and both are frequently found in surface waters. Diclofenac affects organ
histology and gene expression in fish when exposed to a concentration of lµg/l. of this drug
(Cuklev et al 2012). In another Indian study, five common non steroidal anti-inflammatory
drugs (NSAIDS) namely diclofenac, ketoprofen, naproxen, ibuprofen and acetylsalicylic acid
were detected in various concentrations in surface water from 27 locations of the Kaveri vellar
and Tami rapani Rivers in southern India. The samples were extracted by solid-phase extrac‐
tion and analyzed by gas liquid chromatography mass spectrometry (GC-MS). The concen‐
trations of four of the five drugs in this reconnaissance were relatively smaller to those reported
elsewhere being of a value of 200ng/l, however, acetylsalicylic acid, the most readily degrad‐
able of the drugs, investigated was found at all sites and at considerately higher concentrations
of up to 660ng/l, compared to levels reported in European surface waters. The finding of
elevated concentrations of acetylsalicylic acid could be as a result of direct discharges of
untreated sewage. Therefore, readily degradable pharmaceutical may present larger concern
in those regions without consistent sewage treatment. This situation poses risks of direct
toxicity to aquatic wildlife and humans consuming the water (Shanmugan et al 2013).
In another case, effluent from a treatment plant; named Patencheru Environment Technology
(PETL) which is located in an industrial area just outside Hyderabad in India, was observed
to be capable of causing deleterious effects on aquatic vertebrates. In the study,an embryo
toxicity test carried out, observed that as little as 0.2% of the effluent, reduced the growth of
tadpoles by 40%, however the growth of zebra fish (Danio rerio) was not impeded. The median
lethal concentration (LC50) of effluent for zebra fish (Danio rerio) at 144hr after fertilization
varied between 2.7 and 8.1% in different experiments. Although the study focused on fish, it
also increased knowledge about how aquatic vertebrates are possibly affected by effluent
exposures, which substances in the effluent are causing the toxic effects and at what dilutions
of effluent are the fish likely to be affected (Shanmugan et al 2013).
3.1.2. Biofilm
Streams and rivers have been known to be exposed to combinations of different drugs. These
include commonly prescribed medications like anti- diabetics, anti- histamine diphenylhydr‐
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amine of which Benachryl is a brand were (Karatan and Watrick 2009) observed to cause
significant disruption to the biofilm community which is important to the ecosystem. Biofilms
form the slippery coating in stream rocks and are quite vital to stream health where they
contribute to water quality by recycling nutrients and organic matter. They are also a major
food source for invertebrates that in turn feed larger animals like fish. The effects of diphe‐
nylamines on biofilm could therefore have repercussion for animals in stream food web such
as insects and fish (Rosi- Marshall 2013). Other effects of drug contamination of the environ‐
mental were observed in activities of anti-depressant which could trigger spawning in some
shellfish thereby disturbing the ecological balance. Furthermore, propanolol and fluxetine
were observed to have deleterious effects on zooplakton and benthic organisms ( (Hoffman et
al 2005, Rosi-Marshall 2013, NIH 2002).
One of the most important considerations for environmental pharmacology is the impact of
drug contaminants on biofilms. Biofilms are aggregates of microorganisms in which cells that
are frequently embedded within a self produced matrix of extracellular polymeric substances
(EPS) adhere to each other and or to a surface. Biofilm EPS: also referred to as “slime” is a
polymeric conglomeration generally composed of extra cellular DNA proteins and Polysac‐
charides. Biofilms may form on living or non living surfaces and can be prevalent in natural,
industrial or hospital setting (Hall –Stoodley et al 2002, IUPAC 2012, Lear and Lewis 2012).
Quite characteristic of biofilms is their ability to grow in the most extreme environments. For
example, they can survive in the most extremely hot, briny water of hot springs, acidic and
very alkaline waters and frozen glaciers. They can be found on rocks and pebbles at the bottom
of most streams or rivers and often form on the surface of stagnant pools of which they are an
important components of food chains in rivers and streams which are grazed by the aquatic
invertebrates upon which may fish feed. Biofilms are ubiquitous, nearly every species of micro
organism, including bacteria and archea have mechanism by which they can adhere to surfaces
and to each other. They will form on virtually every non shedding surface in a non sterile
aqueous or very human environment. With reference to the immediate human environment,
they can be found growing in shower easily because it provides a moist and warm environment
for them to thrive. They also form inside water sewage pipes causing clogging and contributing
to about 20% of their corrosion.
Biofilms can also affect marine engineering systems such as pipelines of the offshore oil and
gas industry where they may be found causing a substantial corrosion problem. Although
corrosion in the circumstance is mainly due to abiotic reasons. Furthermore, bacterial adhesion
is the foundation for bio fouling of sea bound vessels. Once a film of bacteria forms, it is easy
for other marine organisms such as barnacles to attach. Such fouling can reduce the maximum
speed of the vessels by up to 20% therefore prolonging the voyages with resultant extra
consumption of fuel.They have also been found to be involved in a wide variety of microbial
infections in the body. By one estimate 80% of all infections including intestinal tract infections,
dental plaques gingivitis, catheter infections, and middle ear infections have been associated
with them (NIH 2002). Most recently, it has been observed that bacterial biofilms may impair
cutaneous would healing and reduce topical anti bacterial efficiency in healing or treating
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infected skin wounds (Davis et al 2008). In many animals including man, they build up in teeth
forming dental plaques and causing gum diseases (Rogers 2008, Mihai et al 2010)
The microbial cells growing in a biofilm are physiologically distinct from planktonic cells
of the same organisms which by contrast are single cells that may float or swim in a liquid
medium. Microbes form a biofim in response to many factors which may include cellular
recognition of specific or non specific attachment sites on a surface, nutritional cues, or in
some cases by exposure of  planktonic cells  to sub-inhibitory concentration of  antibiotics
(Hoffman et al 2005; Karatan and Watnick 2009). It is suffice to note that biofilms exhibit
both negative and positive properties. For instance, many sewage treatment plants include
a treatment stage in which waste water passes over biofilms growing on filters which extract
and digest organic compounds. In such biofilms, bacteria are mainly responsible for the
organic  matter,  i.e  biochemical  oxygen demand.  (BOD) While  protozoa and rotifiers  are
mainly responsible  for  the removal  of  suspended solids  including pathogens and micro
organisms. Slow sand filters rely on biofilm development in the same way to filter surface
water from lake, spring or river sources for drinking purposes. Thus what is regarded as
clean water is effectively a waste material to these micro cellular organisms. In addition,
biofilms can help eliminate petroleum oil  from contaminated oceans or marine systems.
The oil  eliminated by the hydrocarbon degrading activities of microbial communities,  in
particular by a remarkable recently discovered group of specialists called “Hydro-carbon-
clastic bacteria” (HCB) (Martins dos Santos et al 2008).
Stromatolites are layered accretionary structures formed in shallow water by the trapping,
binding and cementation of sedimentary grains by microbial films especially of Cyanobacte‐
ria. Stromatolites include some of the most ancient aggregated structures on earth and are still
forming today. Further, biofilms are also useful in microbial fuel cells (MFC) to generate
electricity from a variety of starting materials including complex organic waste and renewable
biomass (Lear and Lewis 2012). The social structure i.e cooperation and competition within a
biofilm highly depends on the species present (Nadel et al 2009). Bacteria living in a biofilm
usually have significantly different properties of free floating bacteria of the same species as
the dense and protected environment of the film allows them to cooperate and interact in
various ways.One benefit of this environment is increased resistance to detergent and
antibiotic as the dense extra cellular matrix and the Outer layer cells protect the interior of the
community. In some cases, antibiotics resistance can be increased a thousand fold (Stewart
and Costerlon 2001). Furthermore, lateral gene transfer is greatly facilitated in biofilms and
this leads to a more stable biofilms structure (Motin and Tolker- Nielen 2003) Other example
of acquisition of resistance by organisms in biofilm could be found in the Legionellea bacteria
and Staphylococcus aereus. Legionella bacteria are known to grow under certain conditions in
biofilms in which they are protected against disinfectants. Workers in cooling towers, people
working in air conditioned rooms and those taking showers are exposed to legionella by
inhalation when the systems are not well designed, constructed or maintained (Murga et al
2001). Sub-therapeutic levels of B-lactam antibiotics induce biofilms formation in Staphylococ‐
cus aereus. This sub-therapeutic level of antibiotics may result from the use of antibiotics as
growth promoters in agriculture, improper disposal of unused drugs or products of excretion
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during the normal course of antibiotic therapy. The biofilms formation induced by low level
methicilin was inhibited by DNAse suggesting that the sub-therapeutic levels of the antibiotic
also induce extracellular DNA release (Kaplan et al 2012)
However, biofilms are not always less susceptible to antibiotics. For instance, the biofilms form
of Pseudomonas aeruginosa has no greater resistance to antimicrobials than do stationary phase
planktonic cells, although when the biofilm is compared to logarithmic phase planktonic cells,
the biofilm does have greater resistance to antimicrobials. This resistance to antibiotics in both
stationary phase cells and biofilms may be due to the presence of persister cells (Spoering and
Lewis 2001).
3.1.3. Diethylstilbestrol (DES)
Diethylstilbesterol (DES) is a synthetic estrogen that is used to prevent miscarriages in women
between 1940s and 1960s. A moderate increase in breast cancer risk has been shown both in
daughter of women who were treated with DES during pregnancy as well as in their grand-
daughters. The expression of 82 mi RNAs (91% of the 898 mRNAs) evaluated were observed
in breast epithelial cell exposed to DES. In particular, the suppression of MIR-9-3 expression
was accompanied by promoter hypermethylation of the MIR-9-5 coding gene in DES treated
epithelial cells.
3.1.4. Contamination with herbal products: Aristolochic acid
Aristolochic Acid (AA) is a natural compound found in many plants of the Aristolochia
genius. Aristolochia plants are commonly used in traditional herbal preparation as health
supplements and remedies for various health problems including weight loss, menstrual
symptoms and rheumatism (Vancher Weghem et al 1993, Kwak et al 2012,). In the 1990s,
epidemiological studies revealed AA exposure was associated with a high risk of nephro‐
toxicity  and  upper  urinary  tract  urothelial  cell  carcinoma  (UTUC)  (De  Broe  et  al  1999,
Grollman et al 2007, Debelle et al 2008, Notier et al 2000) caused by the ability of AA to
bind DNA, forming DNA adduct. (Schmeiser et al 1998). These findings, consequently led
to  ban  on  the  use  of  Aristolochia  containing  herbal  preparations  in  Europe  and  North
America since 2001 and in Asia since 2003 (Debelle  et  al  2008).  Currently,  AA is  classi‐
fied in the International Agency for Research on Cancer (IARC) monograph as a group 1
human carcinogen (IARC 2012).In Taiwan, AA associated DNA adducts was detected in
the renal cortex of more than 50% of UTUC patients (Moriya et al 2011) and incidence of
UTUC of 30% is strikingly higher than in the West with 3% (Yang et al 2002). This figure
is consistent with AA playing a role in Asian UTUC. There is a possibility that AA may
contaminate  surface  water,  grain  and  vegetables  during  the  processing  of  Aristolochia
containing herbs and the disposal of its waste. Aristolochia species are commonly used in
Chinese  herbal  medicine  (Barceleux  2008  et  al,  Henrich  2009,  Gluhovschi  et  al  2011).
Aristolochic  acid  I  is  the  most  abundant  of  the  Aristolochic  acids  found  in  almost  all
Aristolochia species and are often accompanied by aristolactam which has been implicat‐
ed as the causative agent of Balkan endemic nephropathy (BEN), Chinese herb nephrop‐
athy  (CHN)  and  urethelial  cancer  (UC).  When  hay  meant  for  feeding  horses  was
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contaminated with Aristolochia plants, the horses were observed to develop chronic renal
failure. (Grollman 2013).
TP 53 mutation signature in urothelial tumours and the presence of aristolaclam DNA adducts
in the renal cortex defined in the course of research proved to be a robust bio marker of
exposure to this potent nephrotoxin and human carcinogen (Moriya et al 2011). With the
growing influence of herbal drugs worldwide, botanical plants with pharmacological prop‐
erties should be cautiously handled in order not to contaminate crops, vegetables and surface
water. Another common herb which may contaminate the ecosystem is marijuana with the
potential ability to interfere with the biological system of aquatic flora and fauna. In addition,
herbs like St. John’s wort has been observed to cause modulation of Cytochrome p450 and may
interfere with prescribed therapeutic agents (Guegenrich 1997).
3.2. Toxin-environment interaction
It is a well known fact that toxins interact frequently with the environment and some of these
interactions may have deleterious effects on plants animals and man. Some of these effects are
discussed further in this chapter.
3.2.1. Autoimmune diseases
There is a current view that environmental exposure play a role in the development and or the
exacerbation of autoimmune diseases. (Ritz 2010,Bashir et al 2011). Auto immune diseases
result from an immune response directed against the body’s own tissues. There are so many
different auto immune diseases and though many of the individual immune diseases are rare,
autoimmune diseases collectively afflict approximately 24.5million Americans with women
disproportionally affected. The causes of auto immune disorders remain largely unknown.
During reproductive ages (18-40), there is a distinct female preponderance of autoimmune
diseases including and sex hormones and/or sex chromosomes may be responsible for this
enhanced susceptibility (Whitcare et al 1999, Voskuhi 2011). Genetic risk factors have been and
continue to be studied and account for a portion of the risk for autoimmune disorders with
concordance studies in identical; twins generally in the 25 - 40% range. It is becoming clear
from human studies as well as animal model and in vitro research that the etiology of auto‐
immune diseases is multi-factoral involving both genetic and environmental influences.
Existing data and epidemiological evidence supports a role for the contribution of a number
of environmental exposures to the development of specific auto immune outcomes. Included
in this current line of thought were crystalline silica exposure and the development of several
autoimmune diseases including rheumatoid arthritis (RA) systemic sclerosis (SSc) systematic
lupus erythematosis (SLE) and anti-neutrophil cytoplasmic antibody (ANCA) related vascu‐
litis; solvent exposure and the development of SSc, smoking and the development of seropos‐
itive RA; and an inverse relationship between ultraviolet radiation exposure and the risk of
development of multiple sclerosis (MS).Furthermore, animal models of exposure provide
additional support for the role of xenobiotics in the development of autoimmune diseases.
Examples of demonstrated links include: forms of inorganic mercury and the induction of a
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transient systematic autoimmune diseases in rats and mice and the mineral oil component 2,
6, 10, 14 tetramethylphenylenediamine (TMPD or pristane) and an induction of chronic lupus
like disease and inflammatory arthritis in several strains of mice. Animal model studies have
shown additional exposures with likely link to the induction and or exacerbation of auto
immune diseases, including gold, silica, trichloroethylene (TCE), 2, 3, 7, 8, - Tetra dichloro-
dibenzo-p-dioxin (TCDD), organochlorine pesticides and ultraviolet (UV) radiation.The
mechanisms by which environmental factors alter basic biological processes to induce auto
immune diseases continue to be examined, but remain largely unknown. A growing body of
literature points to a number of mechanisms likely involved in environmental exposure-based
auto immunity and include a role for xenobiotics in the activation of Toll-like receptors (TLR);
B Cell activation; impairment of T. helper 17 (Th 17) and T-regulatory (T-reg) cell immune
function; modifications of self antigens; and alteration of DNA methylation profiles. The
cumulative body of research findings is increasing the confidence that specific exposures and
mechanisms are involved in the development of auto immune diseases. Despite growing
advances in the field, an understanding of the interactive roles of the environment and genetics
in the auto immune process is still lacking and additional progress is needed on many fronts
(NIEHS).
3.2.2. Endocrine disruptors
An important aspect of environment toxin interaction (TXE) is the effects of endocrine
disruptors on aquatic system (Le Parge et al 2011). Environmental xenobiotics having oestro‐
genic effects include plants, pesticides, surfactants, plastics and animal genistein, methoxyclor
and bisphenol. They cause lowering of cholesterol on oestrogen dependent animal models and
have been associated as a cause of osteoporosis. Endocrine disruptors (EDC) are chemicals that
may interfere with the production or activity of hormones in living organisms. Perhaps are
the synthetic hormonal drugs such as birth control pills. Others are dioxins polychlorinated
biophenyls (PCB) pesticides, bisphenol A, phthalates, lead, mercury cadmium, arsenic
herbicides; atrazine, plastic residues, and cleaning products. These chemicals can enter the
aquatic system through improper medical waste disposal, runoff from land fill and sewage
discharge from storms (Daughton and Ruhoy 2008, Fent 2006, Genius et al 2012).
3.2.2.1. Wildlife
Because  a  large  proportion  of  potential  endocrine  disruptors  end up in  surface  waters,
aquatic species are particularly vulnerable to their potential adverse effects. Recent studies
identified a number of brain targets for EDC commonly present in environmentally relevant
concentrations in surface waters. Among those normal systems disrupted by EDC are the
gonadotrophin releasing hormone (GnRH) neurons,  the dopaminergic  circuits  and more
recently the Kiss/GPR54 system, which regulates gonadotrophin release. However, one of
the most striking effects of EDC, notably estrogen mimics, is their impact on the Cyp19a1b.
gene that encodes the brain aromatase isoform in fish.  This is  an example in which the
molecular  basis  of  endocrine disruption is  fully  understood.  (Le  Page et  al  2011).  More
commonly observed effects of EDC is impaired reproduction and development in aquatic
Environmental Pharmacology – An Overview
http://dx.doi.org/10.5772/57473
145
animals (Kidd el al 2007).  Furthermore, masculinization (imposex) had been observed in
female marine snails exposed to tributylin (TBT), a biocide used in anti-fouling paints. The
dog whelk “(Nucella lapillus) a species of predatory sea snail’ after is particularly sensitive
and imposex has resulted in decline or extinction of local populations worldwide, includ‐
ing coastal  areas  all  over  Europe and in  the  open North Sea.  DDE –  induced egg-shell
thinning in birds is probably the best example of reproductive impairment causing several
population declines in a number of raptor in species Europe and North America. Develop‐
mental exposure to the DDT complex has been formerly linked to the induction of ovotestis
in male western gulls. EDGs have adversely affected a variety of fish species in the vicinity
of certain sources, for example effluents of water treatment and in the most contaminated
areas, this exposure is causally linked with effects on reproductive organs which could have
implication  for  fish  populations.  Turtles  can  also  be  affected  in  the  in  the  same  way
(Cleuvers 2003,Le Parge et al 2011).
In mammals, the best evidence came from the field studies on Baltic grey and ringed seals
and from the semi-field studies on Wadden Sea harbour seals,  where both reproduction
and immune function hare been impaired by PCBs in the food chain other mammals affected
include the polar bear, rabbit and guinea pig. Distorted sex-organ development and function
in alligators has been linked with a major pesticide spell  into a lake in Florida in USA.
Furthermore,  the  oestrogenic  and  androgenic  effects  observed  in  this  reptile  have  been
causally  linked  in  experimental  studies  with  alligator  eggs  to  the  DDT  complex.  For
terrestrial (land living) wildlife, including aquatic mammals, exposure is primarily expected
to be of dietary origin. The situation is however different for aquatics wild life where direct
uptake of dissolved chemicals from the water is a significant route to exposure.
3.2.2.2. Effect on humans
The possible pathway of exposure to endocrine disruptors in humans, include, direct exposure
at work place, and via consumer products such as food, certain plastic, paints, detergents and
cosmetics as well as indirect exposure via the environment, viz air, water and soil.
In general, the vulnerability of a given species will depend on the intrinsic properties of the
chemical, magnitude, duration, frequency means of exposure and the way in which a given
specie can absorb, distribute, transform and eliminate substances. It will also depend on the
sensitivity of specific organ at different stages of development.The endocrine- disruptor
hypothesis was originally formulated for xenoestrogens i.e chemical which affect the estrogen
signaling pathway. The greatest attention to endocrine disruption has focused on estrogenic
effects but a clear cause-effect relationship has not yet been established. (Meeker 2012, EC2013,)
However, it is now becoming generally accepted that compounds of various types can interact
with different component in several cell regulatory systems including the steroid and thyroid
hormone receptor families. Apart from the drug DES (synthetic oestrogens), environmental
oestrogens have never been proven to cause human health problems. At best there can only
be speculation on possible human health effects by interpolation of documents obtained from
animal studies (Hollander 1997) EDCs which act via receptors of the steroid receptor super
family can have effect on many organs of the body. Steroid receptors for oestrogens, androgens
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and adrenocorticoid and thyroid hormones are found in practically all cells of the body. The
functions of the brain, the cardiovascular, the skeletal and the urogenital system are regulated
by these hormones and can therefore be affected by EDCS. In addition, an EDC with a defined
action in one organ; for example estrogenic activity can extent similar or non-oestrogenic effect
or even antagonistic effects in other organs.
3.2.2.3. Potential effect in males
EDCS has the potential to cause poor semen quality including low sperm counts, low ejaculate
volume, high number of abnormal spermatozoa motility. Other effects may include testicular
cancer, malformed reproductive tissue. viz undescended testes, small penis size, prostate
disease and other unrecognized abnormalities of male reproductive tissues. In infertility
studies, the effects of environmental pollution including occupational exposures are currently
being given due consideration.
3.2.2.4. Potential effect in females
There are currently putative links between EDC and some female diseases including breast
and reproductive organ tissue cancers, fibrocystic disease of the breasts, polycystic ovarian
syndrome, endometriosis, uterine fibroid and pelvic inflammatory diseases.
3.2.2.5. Potential effect in children
EDCS have been linked with impaired behavior, mental, immune and thyroid functions in
developing children. Other include precocious puberty, osteoporosis, foetal growth, child
development, and obesity (Meeker 2012)
3.3. Environmental pharmacology and the pediatrics population
Although non therapeutic xenobiotics represent the vast majority of environmental exposures
during childhood, studies of these compounds in children has lagged behind drug studies.The
paediatric group is unique with respect to environmental contaminants in that there is a lot of
hand to mouth activities ranging from food stuff to drug and plastic toys. They are also quite
vulnerable to poisoning from unprescribed medications. However, an increased impetus for
paediatric pharmacology studies resulted from evidence of short comings in algorithmic
approaches to dosing and the recognition of differing efficacy. While in some drugs develop‐
mental differences resulted in increase toxicity or failed efficacy. In others decreased toxicity
was observed and toxicity in children compared to adults. Thus the paediatric patients may
not be classified arbitrarily as a susceptible population, but however, certainly a different
group compared with the adults. Better designed pediatric pharmacology studies use well
documented, non linear changes in body composition across childhood, as well as knowledge
about the impact of physical growth, mediated by complex normal changes. Developmental
differences in all component of drug disposition, including absorption, distribution, metabo‐
lism and excretion have been characterized. Of these, the ontogeny of metabolism, particularly
tissue specific metabolism, is the most complex. Many knowledge gaps still persist within
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developmental pharmacology (McCarver 2004). The most common concern for pediatric
environmental pharmacology are the EDCs. While human epidemiology studies of exposure
to EDCs and children’s health remain extremely limited, a growing body of evidence show
that exposure to a number of chemicals commonly found in consumer goods, personal care
products, food drinking water, and other sources may adversely affect child development
through altered endocrine function. Some of which include persistent organic pollutants (POP)
phthalates, bisphenol A and contemporary use pesticides had earlier been discussed in this
chapter.
Each year, nearly 1,500 children under 6 years old are treated in U.S. emergency depart‐
ment as a result of accidental ingestion of buprenorphine. A new study examines 2,3800 of
these cases for October 2009 to March 2012. Buprenorphine brand name (subutex) is used
alone or in combination with another drug called naloxone (brand name suboxone) to ease
the symptoms of withdrawal in people trying to beat addictions to herein, certain prescrip‐
tion pain killers and other opoid drugs. One dose of this medication can be fatal to a small
child.  Other  commonly  used  medications  such  as  high  blood  pressure  medicals,  some
diabetic drugs, strong pain killers, some medications used for arthritis, and some drugs for
attention deficit/hyperactivity disorder can potentially be fatal to a small child with just a
single dose. (Lavonas 2013).
3.4. Miscellaneous toxicity
Bisphenol A, a component used in many plastic products binds to the local anaesthetic receptor
site to block the human cardiac sodium channel (O Really et al 2012). Nickel, chromium arsenic
and lead are well known environmental toxicant. Many household products like insecticides,
paints, cosmetics, cleaning fluids, nano-materials based items are known to contain some of
these toxicants. While they may not be directly toxic, their interaction with cellular organelles
may result in cancer. Lead is known to be hepatotoxic while cadmium is a well known
nephrotoxic agent. Phthalates which is commonly used in cosmetics like nail polish are thought
to affect the endocrine system and are being investigated for a link with infertility in women
3.4.1. Household products
Many household products are potentially dangerous substances, and these include oven and
drain cleaners, laundry powder, floor polish, paint and pesticides. Even arts and craft supplies
and yard care products can be hazardous. Many household products can harm children pets
and the environment if not correctly stored, used and disposed of. Toxic substances in these
products can cause harm if inhaled, swallowed or absorbed through the skin.
Based on genetic composition, people respond to toxic substance might cause birth defects or
other sources problems including brain damage or death. The concept of 3Rs viz reduction,
reuse and recycling is bound to minimize amount of drugs in the environment.
Household waste (HHW): reduction, reuse, recycling and finally disposal
• Reduction and recycling of HHW conserves resources and energy that would be expended
in the production of more products
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• Re use of hazardous household products can save money and reduce the need for generating
hazardous substances
• Proper disposal prevents pollution that could endanger human health and the environment
3.4.2. Pesticides
Pesticides can be fungicides, herbicides and rodenticides. Pests live where they are not wanted
or cause harm to crops, people or animals and pesticides have been useful agents in getting
rid of them..Pesticides can be very helpful in the sense that they protect man’s health by killing
germs, animals or plants that can hurt us. However, most pesticides can be harmful to people
and pets. Disposing of pesticides properly is also important as it can protect the environment.
Biologically based pesticides are becoming more popular as they often safer than traditional
pesticides. They come in the form of pheromones and microbial pesticides.
Pesticides are classified as semi volatile organic compounds and include a variety of chemicals
in various forms. They are chemicals that are used to kill or control pests which include
bacteria, fungi and other organisms. In addition, to insects and rodents Pesticides are inher‐
ently toxic. Health effects of pesticides include irritation to eye, nose, throat, damage to central
nervous system and kidney and increased risk of cancer. Symptoms of pesticide toxicity
include headache, dizziness, muscular weakness and nausea. Chronic exposure to some
pesticides can result in damage to the liver, kidneys, endocrine and nervous systems both the
active and inert ingredients in pesticides can be organic compounds; therefore, both could add
to the levels of airborne organics inside homes. Furthermore, both types of ingredients can
cause the type of effects obtained in either house hold chemical products like those seen in
volatile organic compounds (VOCs). However, as with other household products, there is an
insufficient understanding at present about what pesticide concentrations are necessary to
produce these effects. Exposure to high levels of cyclodiene pesticides commonly associated
with misapplication had caused various symptoms, including headaches, dizziness, muscle
twitching, weakness, tingling sensation, and nausea. It is also thought that cyclodienes might
cause long-term damage to the liver and the central nervous system as well as an increased
risk of cancer. Subsequently, in the U.S, no further sales or commercial use were permitted for
the following cyclodiene or related pesticides: chlordene, aldrin, dieldrin and heptachlor. The
only exception however is the use of heptachlor by utility companies to control fire ants in
underground cable boxes.
Safe pesticides
Ninety percent of pesticides currently in use are synthetic, however, in the last two decades
there had been conscious attempts to develop safe and environmentally friendly pesticides.
Organic or natural pesticides have received the most acclaim and certain have the endorsement
of environmentalists. It has also become increasingly likely that some synthetic pesticides such
as (DDT), were not poor choices, but misused and overused thus leading to many reputable
environmental groups urging that the use of DDT be reconsidered because its effectiveness is
unrivaled and causes minimal collateral damage when properly applied. At the same time,
organic pesticides are becoming increasingly effective and affordable. They now command
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over 10% of the pesticide market in the United States. The paradox of organic or biopesticides
is that the product and genetically engineered organochlorine is natural, being a fungus, virus
or bacteria making it an interesting products to the environmentalists. Synthetic pesticides
such as organophosphate and organchlorine insecticides have been associated with everything
from cancer to neurological disorders and lung irritations in humans. However, these symp‐
toms are unlikely, if not impossible to get from a healthy dose of fruits or vegetables. A variety
of pesticides such as mineral oil, malathion, sulphur dimethylamine and many others re used
to control fungi and insects on wheat and cereals. It is therefore naïve to think that humans
can totally avoid ingestion of pesticides. Chlorinated hydrocarbons present in synthetic
pesticides such as methoxychlor, endosulfan and captain accumulate in fatty tissue because it
is not completely filtered from the system. Healthy humans can detoxify the body over time
and the levels are rarely high enough to do any real harm (Ecoworld 2004).
Biological pesticides or biopesticides
Biological pesticides are pesticides based on microorganisms or natural products (Coombs
2013). They are typically created by growing and concentrating naturally occurring organisms
and or their metabolites including bacteria and other microbes, fungi, nematodes, proteins etc.
They are often considered to be important components of integrated pest management (IPM)
programmes and have received much practical attention as substitutes to synthetic chemical
plant protection productions (PPPs). (Coping 2009). Biopesticides are divided into three major
classes and these include:
i. Microbial pesticides which consist of bacteria, entomopathogenic fungi or viruses
and sometimes includes the metabolites that bacteria of fungi produce. Entomopa‐
thogenic hematodes are also often classified as microbial pesticides, even though they
are multi-cellular (Coombs 2013).
ii. Biochemical pesticides: these are naturally occurring substances that control or
monitor in the case of pheromones, pests.
iii. Plant: incorporated protectants (PIPs): which have genetic material from other species
incorporated into their genetic material i.e. genetically modified crops (GMCs). There
have been a lot of controversies on (GMSs). In many European countries it is pertinent
to note that apart from the biological activity of biopesticides against insect pests,
nematodes, fungi and other organism, they usually have no known function in
photosynthesis, growth and other basic aspects of plant physiology.
Applications of biopesticides is similar to chemical pesticides and are becoming widely used
due to their environmental friendliness and biodegradability.
Examples of biopesticides include
i. Bacillus thuringiensis toxin, (BE Toxin) genetically incorporated into plants as insec‐
ticide. There is however controversies associated with use of BT toxin which has been
observed to have a negative impact on the liver and kidneys of mammals with
contaminated Bt toxin in their diet (Kilie and Akay 2008).
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ii. Entomopathogenic fungi (e.g. Beauveria bassiana, Lacanicillum spp, Metarinzium spp.
iii. Disease controling agents such as Trichoderma spp and Ampelomyces quisqualis
iv. Beneficial nematodes attacking insects e.g. Sleinernema fetiae or slug pest such as
Phasmarhabditis hermaphrodita.
v. Entomopathogenic viruses e.g. Cydia pomonella granulo virus.
vi. Insect pheromones and other semio chemicals.
vii. Fermentation products such as spinosad (a macro-cylic lactone)
viii. Chitosan: a plant to which this product is applied will naturally induce systemic
resistance to allow the plant to defend itself against disease, pathogen and pests
(Benhamou et al 1994).
ix. Natural plant derived products such as alkaloides terpenoids, phenolics and secon‐
dary chemicals. Certain vegetable oils are known to have pesticidal properties. In
addition, products based on extracts of plants such as garlic have now been registered
in the European Union and other places.
x. Naturally occurring minerals such as baking soda are also thought to have pesticide
properties.
Biopesticides have advantages and disadvantages over the conventional chemical pesticides
and these advantages include non detection of harmful residues, cost effective, biodegradable
and in some cases more effective Their disadvantages include high specificity, slow pace of
action, variable efficacy and the potential of ability of target organism to acquire tolerance as
living organisms evolving.
3.4.3. Triclosan
Triclosan (TCS) is a broad spectrum antimicrobial compound that is incorporated into
numerous consumer products. Triclosan which is contained in about half of liquid soaps
functions by slowing or stopping the growth of bacteria, fungi and mildew. Triclosan fre‐
quently gets into streams and rivers through domestic waste water, leaking sewerage and
sewage overflows. The bacterial resistance caused by triclosan was found to disrupt aquatic
life by changing natural bacterial communities leading to emergence of resistance bacteria that
could diminish the usefulness of important antibiotics (Drury et al 2013).
3.4.4. Criminal Environmental xenobiotic pollution
There had been recent cases of pollution of the environment with criminal intents. One of the
most notable is the use of Aldicarb (Temik) a carbamate insecticide which is extremely toxic
to mammals and has been widely used by wildlife poachers in South Africa for many years to
poison rhinos and other wild life species. Aldicarb is also used by burglars to poison sentry
dogs, and the general public to destroy rats and stray dogs. Although banned in South Africa,
it is readily available in Zimbabwe and Mozambique and large quantities are smuggled into
South Africa for illegal sale there.
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Temik is widely used normally as a pesticide on crops such as cotton, potatoes and peanuts
and it is registered under the terms of The Fertilizers, Farm Seeds, Agricultural and Stock
Remedies Act of 1947. As a member of the carbamate pesticides, classification is divided into
super high and medium toxicity. By implication, it falls within the super toxic class which
males its highly toxic. It takes ½ - 1½ hour for symptoms to show and intoxication lasts up to
six to eight hours. Fatality is due to asphyxiation as the lungs are flooded with secretion from
the stomach. A teaspoon is enough to kills a grown rhinoceros while 1 µg can kill a rodent,
making it more poisonous than arsenic. Rhinos are targets in Africa and Asia for their horns
which fetch high prices in Yemen where they are prized for making dagger handles and in
East Asia where they are used in traditional medicine Application of Temik and other
xenobiotics like cyanide for criminal intent of poaching is by lacing watering holes of the
animals with the said substances. ( Promed 2013)
Successful treatment of animals poisoned with aldicarb is the timely treatment with anti-
muscarinic drugs such as atropine with additional supportive treatment options including
fluid therapy, diphenylhydrazine, benzodiazepams and prevention of further absorption
using activated charcoal (Amot et al 2011). Early treatment can be very successful. In areas like
South Africa where such practice is endemic, pet owners are advised to keep their dogs inside
or in a backyard at night and pets should be fed at night to prevent them from eating poisoned
baits. Furthermore obedience training of dog to prevent food acceptance from strangers is also
advised. At one of the veterinary clinics in Gauteng Province in South Africa, in 2003, 97 cases
of aldicarb poisoning were diagnosed (Amot et al 2011). However, the intentional, malicious
poisoning of dogs and other species is not restricted to South Africa alone, there are reports of
other large scale practices in USA and Spain (Wassem et al 2012). It has also been reported that
aldicarb is illegally used as a household rodenticide in Brazil and the Carribean Island and
sometimes human beings are victims. (Ragoucy-Sengler 2000).
3.4.5. Natural health products (NHPs)
Recent evidence have shown that natural health products (NHPs) therapies are increasingly
recommended by various health providers, including conventional physicians leading to
increased consumption of vitamins and many herbal agents worldwide. According to WHO
estimates, the present demand for medicinal plants is about US $14 billion a year and it is
estimated to likely increase to about $5 trillion by the year 2050. The high prices and sometimes
established side effects of synthetic drugs have caused many people to find alternatives in
herbal medicine when faced with options. There are however concerns about safety and
efficacy of herbal medicine due to lack of regulation and some reported adverse effects.
Although the WHO has developed guidelines for the quality control of herbal drugs which
provide a detailed description of the techniques and measures required for the appropriate
cultivation and collection of medicinal plants, there is still a lacuna between this available
knowledge and implementation because the cultivators of herbs for medicinal uses are usually
unaware of the regulations and these products may be contaminated with banned pesticides,
microbial agents like fungi, heavy metals and chemical toxins which may cause adverse
outcomes such as sensori-neural defects, congenital paralysis, liver and kidney damage. These
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contaminants may be related to the source of the herbal drugs. Chemical toxins may come
from unfavorable post harvest techniques, wrong storage conditions or through chemical
treatment during storage period. Some of these environmental factors may be controlled by
implementing good source; good agricultural practices and standard operating procedures
(SOP) for producing good quality herbal products.
In a recent study conducted in Boston, USA on Indian ayurvedic medicines, it was observed
that ayurvedic medicine obtained from 30 South Asian store in the Boston area had potentially
harmful levels of lead, mercury and arsenic. These metals were found in the products like “bal
guti”, mahayograj guggulu”, mahalaxmi vilas ras” safi, shilajit and etc in some of the leading
stores within the ayurvedic communities. Therefore, users of the medicines may be at risk of
heavy metal toxicity similarly; Koh and Woo (2000) reported excessive toxic heavy metals in
Chinese proprietary medicine in Singapore during the year 1990-1997.
In addition Wong et al (1993) also reported concentration of nine heavy metals; viz cadmium,
cobalt, copper, iron, manganese, nickel lead, zinc and mercury in 42 Chinese herbal drugs. The
concentration range of the stores of metals were comparable to that reported in many of the
East Asian vegetables and fruits. Few samples contained a higher concentration of toxic metals
such as calcium, lead and mercury. This report suggested that the presence of heavy metals
was probably caused by contamination during air drying and preservation (Rai and Mehrotra
2005). Whether an element is toxic or not is determined by many factors including route of
exposure, dose, site of accumulation, nutritional status, detoxification biochemistry and the
particular form of species in which the elements exists within the body. Different species of
elements have the potential to display distinct toxicity patterns for example, hexavalent
chromium (chromium VI) is highly toxic and carcinogenic while trivalent chromium (chro‐
mium III) is an essential metal involved in lipid and carbohydrate metabolism.Similarly,
inorganic and organic arsenic are both naturally occurring compounds that display different
toxicities. While certain inorganic arsenic species are classified as human carcinogens, some
form of organic arsenic such as arsenobetaine (which accumulates in some aquatics organisms
such as shrimp) are relatively non – toxic specific forms of some elements also have the
potential to be converted within the body to different forms; which changes their properties
and potential toxicity.
Most natural health products tested showed detectable contamination with one or more toxic
elements, the degree of contamination appears to be linked to the country of manufacture with
higher contamination from mercury, arsenic and aluminum primarily found in products
imported from China. Marine –sourced NHPs usually have the highest level of lead contam‐
ination while non-marine sourced NHPs manufactured in North America generally demon‐
strated the least contamination among samples tested. Although marine sourced and
ayurvedic NHPs were almost often contaminated, the levels rarely exceeded established
toxicity guidelines (Genius et al 2012).
3.4.6. Chlorination of water
The most common disinfection method involves some form of chlorine or its compounds such
as chloramines or chlorine dioxides. Chlorine is a strong oxidant that rapidly kills many
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harmful micro organisms. Because chlorine is a toxic gas, there is a danger of a release
associated with its use. This problem can be avoided by the use of sodium hypochlorite, which
is a relatively inexpensive solution that releases free chlorine when dissolved in water. The
generation of liquid sodium hypochlorite is both inexpensive and safer than the use of gas or
solid chlorine. One drain back is that chlorine from any source reacts with natural organic
compounds in the water to form potentially harmful chemical by products. These by- products
include triethylin, trihalomethanes (THMs) and haloacetic acids (HAAs) are carcinogenic in
large quantities and are regulated in the United States of America by the Environmental
Protection Agency. For example, rats chronically intoxicated with triethylin drinking water,
demonstrated cerebral oedema as well as an increase in phosphatidyl ethanolamine-n-methyl
transferase activity. The increased methylation might be a compensatory mechanisms for
counteracting the membranes damages induced by triethylin. Furthermore, chloroform,
dichloroacetic acid (DCA) and trichloroacetic acid (TCA) which are known liver and kidney
carcinogens are by product of chlorine disinfection found in drinking water. In mice treated
with these three chlorine by products, hypermethylation and increased expression of c-myc-
c a proto-oncogene involved in liver and kidney tumours were observed. Trihalomethanes viz
chloroform, bromo-dichloromethane, chloro-bromomethane and bromoform are regulated
organic contaminants in drinking water. Experimental evidences in the female B6C3F1 mouse
liver demonstrated carcinogenic activities of the tri-halomethanes. Chloroform and bromo-
dichloromethane were observed to decrease the concentration of 5- methyl-cystosine in hepatic
DNA. Methylation in the promoter region of the c-myc gene was reduced by the tri-halome‐
thanes, a process consistent with carcinogenic activities. The formation of THMs and haloacetic
acids may be minimized by effective removal of as many organics from the water as possible
prior to chlorine addition. Although chlorine is effective in killing bacteria, it has limited
effectiveness against protozoa that form cysts in water (Girdia lamblia and Cryptosporidium, both
of which are pathogenic).
Alternatives to elemental chlorine disinfection include chlorine dioxide disinfection, chlora‐
mines disinfection, ozone disinfection and ultraviolet disinfection.
i. Chloride dioxide disinfection: Chlorine dioxide is a faster acting disinfection than
elemental chlorine. It is relatively rarely used because in some circumstances it may
create excessive amount of chlorite, which is a by-product regulated to low allowable
levels in the United States. Chlorine dioxide is supplied as an aqueun solution and
added to water to avoid gas handling problems, chlorine dioxide gas accumulations
may spontaneously detonate.
ii. Chloramines disinfection: the use of chloramines is becoming more common as a
disinfectant. Although chloramines is not as strong as oxidant, it does provide a
longer-lasting residual than free chlorine and it won’t form THM’s or haloacetic acids.
It is also possible to convent chlorine to chlorine by colding ammonia to the water
after addition of chlorine. The chlorine and ammonia reacts to form chloramines.
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3.5. Gene environment interaction (GXE)
Every human start life with a particular set of genes of about 20,000 to 25,000. Chemicals may
not necessarily cause mutation of genes but may send subtle signals that silence them or switch
them on at the wrong times. Chemicals in our environment and food can alter the genes,
leaving the exposed, vulnerable to a variety of diseases and disorders including diabetes,
asthma, cancer, and obesity. It may therefore be expedient to start testing chemicals for these
effects.
3.5.1. Toxicogenomics: environmental epigenetics
Toxicogenomics is a field that emerged from conventional toxicology with functional genom‐
ics. In recent years, this field contributed immensely in defining adverse biological effects
resulting from environmental stressors; toxins, drugs and chemicals. Through micro array
technology, large scale detection and quantification of mRNA transcripts and microRNA
related to alterations in mRNA stability or gene regulation becomes feasible. Other omics
technologies, notably proteomics and metabolomics soon joined in providing further fine
turning in the gathering and interpretation of toxicological data. A field that will inevitably
modify the landscape of toxicogenomics is epigenetics, a term referring to heritable changes
in gene expression without the accompanying alterations in the DNA sequence. These
epigenetic changes may result from mechanism such as DNA methylation, histone modifica‐
tion and non coding RNAs in the regulation of gene expression. Epigenetic mechanisms are
essential in normal development and differentiation but these can be misdirected leading to
diseases notably cancer. There is now a mounting body of evidence that environmental
exposure particularly in early development can induce epigenetic changes which may be
transmitted in subsequent generations or serve as basis for diseases developed in later life.
Either way, epigenetic mechanisms will help interpret toxicological data or toxicogenomic
approaches to identify epigenetic effects of environmental exposures. Thus a full understand‐
ing of environmental interactions with the genome requires keeping abreast of epigenetic
mechanisms as well as conducting routine analyses of epigenetic modifications as part of the
mechanisms of actions of environmental exposure. For example epigenetic modification was
observed in the tumour suppressor gene Tsrc1 (1-gsf4a) obtained from transgenic mouse
models.
The genome is dynamic and responsive to environmental signals not only during development
but also throughout life and it is becoming increasingly apparent that chemicals cause the
changes in gene expression that persist long after the exposure has ceased. Commonly used
pharmaceutical drugs can cause persistent epigenetic changes. By altering epigenetic homeo‐
stasis by direct or indirect mechanisms. Direct effects may be caused by drugs which affect
chromatin architecture or DNA methylation. For example the anti-hypertensive hydrazine
inhibits DNA methylation while isotretinoin has transcription factor activity. A two tier
mechanism is postulated for indirect effect in which acute exposure to a drug influences
signaling pathways that may lead to an alternative of transcription factor activity of gene
promoters. This stimulation results in the altered expression of receptors signaling molecules
and other proteins necessary to alter genetic regulatory circuits. With more chronic exposure,
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cells adapt by an unknown process that results in more permanent modification to DNA
methylation and chromatin structure leading to enduring alteration of a given genetic network.
Therefore, any genetic side-effects caused by a drug may persist after the drug is discontinued.
Some iatrogenic  diseases  such as  ‘tardive  dyskinesia’  and drug induced systemic  lupus
erythematosis (SLE) may be epigenetic  in nature.  Furthermore,  epigenetic  side effects of
pharmaceuticals may be involved in the aetiology of heart disease, cancer neurological and
cognitive disorders, obesity, diabetes, infertility and sexual dysfunction. It is suggested that
a  systems  biology  approach  employing  micro  array  analyses  of  gene  expression  and
methylation patterns can lead to a better understanding of long term side effects of drugs
and in future epigenetic  assays should be incorporated into the safely assessment of  all
pharmaceuticals  drugs.  Some  environmental  chemicals  enable  methyl  group  to  attack
normal genes turning them off or muting them at a time when they should be turned on.
When such genes  are  turned off,  they can’t  direct  the  manufacture  of  proteins  that  are
essential  for  proper  cell  function.  Chemicals  can  also  uncoil  parts  of  the  chromosomes
causing genes to be expressed or turned on at inappropriate times.  In a recent study in
New  York  City,  it  was  observed  that  children  exposed  in  the  womb  to  high  levels  of
polycyclic  aromatic  hydrocarbons (PAH),  a  common air  pollutant  from traffic  emissions
were more likely to have asthma than those not exposed. Using cord blood for the analysis,
it was observed that a particular gene (AC SL3) was methylated in the exposed children
but not methylated in the unexposed ones. The result was suggestive that the abnormal
methylation pattern probably caused the asthma. (Weksberg et al 2010).
Epigenetic changes have also been observed with children conceived with assisted reproduc‐
tive technologies. One of the disorders that occur at a higher rate in these children is ‘Beckwith-
Wiedemann syndrome’, a disease characterized by abnormal wall defects and a higher risk of
certain childhood cancer (Weksberg et al 2010 ). Beckwith-Wiedemann syndrome is a condition
that affects many parts of the body. It is classified as an overgrowth syndrome, which means
that affected infants are considerably larger than normal (macrosomia) and continue to grow
and gain weight at an unusual rate during childhood. Growth begins to slow by about age 8,
and adults with this condition are not unusually tall. In some children with Beckwith-
Wiedemann syndrome, specific parts of the body may grow abnormally large, leading to an
asymmetric or uneven appearance. This unusual growth pattern is known as hemihyperplasia
The signs and symptoms of Beckwith-Wiedemann syndrome vary among affected individuals.
Many people with this condition are born with an opening in the wall of the abdomen (an
omphalocele) that allows the abdominal organs to protrude through the navel. Other abdomi‐
nal wall defects, such as a soft out-pouching around the belly-button (an umbilical hernia), are
also common. Most infants with Beckwith-Wiedemann syndrome have an abnormally large
tongue (macroglossia), which may interfere with breathing, swallowing, and speaking. Other
major features of this condition include abnormally large abdominal organs (visceromegaly),
creases or pits in the skin near the ears, low blood sugar (hypoglycemia) in infancy, and kidney
abnormalities. Children with Beckwith-Wiedemann syndrome are at an increased risk of
developing several types of cancerous and noncancerous tumors, particularly a rare form of
kidney cancer called Wilm’s tumor, a cancer of muscle tissue called rhabdomyosarcoma, and
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a form of liver cancer called hepatoblastoma. Tumors develop in about 10 percent of people
with this condition and almost always appear in childhood. About one in five infants with
Beckwith-Wiedemann syndrome dies early in life from complications related to the disorder.
Older children and adults are much less likely to have serious medical problems associated
with the condition. With respect to in vitro fertilization, it was postulated that the culture
medium where fertilized eggs were grown for several days before implantation probably
caused the syndrome. The possibility that the different media used for the eggs might contain
a chemical contaminant that stimulate the addition of methyl group to the cells.
Some toxic metals have also been implicated to having epigenetic effects. For example nickel,
chromium and arsenic are well known not because they are toxic to cells, directly but due to
the fact that they cause increased DNA methylation which may result in gene silencing, cell
transformation and subsequently cancer (EHN 2011)
3.5.2. Histone modifications
In humans, protection and packaging of the genetic materials are largely performed by histone
proteins which also offer a mechanism for regulation of DNA, transcription, replication and
repair. Histone are nuclear globular proteins that can be covalently modified by acetylation
(AC) methylation, phosphorylation, glycosylation, sumoylation ubiquitination and adenosine
diphosphale (ADP) ribosylation thus influencing chromatin structure and gene expression.
The most common histone modification that have been observed in environmental chemical
exposure are acetylation and methylation of lysine residues in the amino terminal of histone
3 (H3) and H4. Histone acetylation with only a single acetyl group added to each amino acid
residue usually increases gene transcription activity. Whereas, histone methylation found as
mono (me) dimethyl (me2) and trimethyl (me3) groups states can inhibit the increased gene
expression depending on the amno acid position that is modified.
3.5.3. Environmental antibiotic resistome
Antimicrobial drug resistance is caused by microbial gene products that attenuate the activity
of an antibiotic in an otherwise- drug sensitive organism. Bacteria easily acquire resistance
gene even in the absence of selection. Hospitals are well known hot spots for the acquisition
amplification and dissemination of resistance genes because of the steady supply of strong
selective pressure through the prevalent use of antibiotic therapy (Gaze et al 2013)
The failure of antibiotics that were previously effective in controlling infectious diseases is a
serious phenomenon that gravely affects the human health. The gene that confers resistance
to pathogen was thought to originate from non pathogenic environmental microbes. This
environmental resistome, its mobilization and the conditions that facilitate its entry into
human pathogens are at the heart of the current public health crisis in antibiotic resistance.
Therefore understanding the origins, evolution and mechanism of transfer of resistance
elements is vital to the ability to adequately address this public health issue. Recent advances
in microbial ecology have revealed the extensive presence of antibiotic resistance genes in
environmental bacteria from human polluted; agricultural and pristine soils. The bioactive
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products and the mechanism for resistance are diverse bearing in mind the varieties of
microbes on the earth. The environmental resistome offers a vast reservoir of genes that have
the potential to be mobilized into the antibiotic drug-sensitive cadre of bacterial human
pathogens.
One of the distinctive characteristics of microbial genomics is the movement of genes vertically
through populations by cell division and horizontally across species and genera. This move‐
ment is enabled by the “mobilome”, the genetic element that enable and contribute to the
horizontal gene transfer (HGT) (Si et al 2009). The mobilome is key to the spread of genes
encoding resistance to antimicrobial drugs and heavy metals and for pathogenic traits among
bacteria. Because these functions are often co-located on the same mobile elements, selection
for 1 phenotype inadvertently selects for its unintended (and often recognized) companion.
For example, selection for heavy metal or biocide resistance is often accompanied by antimi‐
crobial drug resistance elements selection for resistance to 1 drug can co-select for 1 of many
other (45 genes in 1 notable example) The scale of genetic transfer ranges from short gene
segments to mega-bases of DNA depending on the transfer mechanism involved. Thus, even
physically distant genes can be co-selected. These facts form a reality that offers cautionary
tales for the substitution of 1 drug for another in response to resistance in clinical or agricultural
setting or for the use of metals (or exposure to them) that can co-select for antimicrobial drug
resistance. Furthermore, plasmids can encode toxin/antitoxin systems that result in plasmid
addiction even in the absence of selection. The net result is an exploded mobile meta-genome
of shared genetic traits that is fluid and readily promulgated through microbial populations.
The rapid movement of water, plants, animals, soil, and humans across the planet virtually
ensures that such traits and associated organism, once easily ecological segregated, can move
seamlessly through habitats across the globe. The result is that no regions are safe or can escape
the introduction and movement of antimicrobial drug-resistant organisms and their genes.
In addition, the antimicrobial drugs themselves, toxins and other compounds can favour
genetic exchange and increase genetic diversity. Three principal mechanisms are involved in
HGT and these include; conjugation (direct cell to cell transfer), transduction (phage-assisted
transfer) and natural transformation (DNA to cell transfer). These mechanisms mobilize
genetic elements such as plasmids, genetic islands and phages that can contain resistance
elements (Colomer-Llurch et al 2011). The environmental hot spots for horizontal gene transfer
(HGT) have been identified and they include the soil particle pores, air-water interfaces in the
aquatic environments and biofilms formed on multiple surfaces. Other hot spots include
sewage treatment plants where a wide range of chemicals meet human and environmental
bacteria in high numbers and manure lagoons where bacterial densities and antimicrobial drug
concentrations can be very high and exposure periods lengthy; aquaculture ponds that are
routinely treated with antimicrobial drugs, biofilters used in degrading pesticides and
environments contaminated by discharge from waste water treatment plants from antimicro‐
bial drug manufacturing. It is therefore instructive that all efforts should be made to minimize
the release of antibiotics into the environment.
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3.5.4. Insecticide resistance gene in insects: the case of bed bugs (Cumox lecturlaries)
Perhaps one of the fall out of environmental pollution with insecticides is the development of
resistance gene in insects. Although no putative link has been proven, recent discovery of
resistance genes in bed bugs makes it plausible. Recent advances in genomic and post genomic
technologies have facilitated a genome wide analysis of the insecticides resistance - associated
genes in insects. A good example is the observation of resistant genes in bed bugs. Bed bugs
(Cumox lecturlaries) are parasites that suck human blood. They come out at night and take five
to eight minutes to feed and then return to cracks and crevices where they aggregate. In a
recent study, a survey of the entire genome of 21 different bed bug population from cities
around the Midwestern region of the United States of America (USA), identified 14 genes
(molecular markers) that are associated with pyrethroid resistance. Pyrethroids are the
chemicals that have been used as the first-line agent against bed bug infestation. Most of the
resistance associated genes are functioning in diverse mechanisms and are expressed in the
epidermal layer of the integument, which could prevent or slow down the toxin from reaching
the target sites on the nerve cells where an additional layer of resistance (kdr) is possible. This
strategy that has evolved in bed bugs is based on their unique morphological, physiological
and behavioural characteristics and has not been reported in any other insect species. RNA
interference – aided knock down of resistance associated genes showed the relative contribu‐
tion of each mechanism towards overall development. Blocking these special genetic defenses
in the laboratory is a relatively straight forward process. The bugs were simply injected with
strands of RNA that interfere with gene expression. When these genes are blocked, the bed
bugs once again became susceptible to pyrethroids. The challenge now is how to transmit
strands of interfering RNA to wild bed bugs. Furthermore, understanding the complexity of
adaptive strategies employed by bed bugs will help in designing the most effective and
sustainable bed bug control methods (Zhu et al 2013)
4. Pharmaceutical disposal and environment standard
4.1. Good manufacturing practice (GMP)
Good manufacturing practice or (GMP) are practices and the systems required to be adapted
in pharmaceutical manufacturing, quality control, quality system covering the manufacture
and testing of pharmaceutical or drugs including active pharmaceutical ingredients, diagnos‐
tics, foods, pharmaceutical industry in over one hundred countries worldwide, primarily in
the developing world. So far, emissions into the environment are not included.
4.2. Disposal of unused medicines
Although medicine play an important role in the treatment of many conditions and diseases,
when they are no longer needed, it is important to dispose of them properly to avoid harm to
others and the environment. Some of the well established methods of disposal include.
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i. Medicine take back programs: this is are good way of removing expired, unwanted
or unused medicine. In most advanced countries, these are well established but such
programs are absent in developing economies.
ii. Disposal in household trash: this should be placed in a sealed plastic bag to prevent
them from getting to the environment before they reach the treatment sites.
iii. Flushing of certain medicines. There is a small number of medicines that may be
especially harmful and in some cases fatal with just one dose if they are used by some
one other than the person for whom the medications was prescribed. To prevent
accidental ingestion by children, pets or any other persons, such medicine are flushed
down the toilets or sinks as soon as they are no longer needed. However, there should
be caution in the application of this disposal method due to current environmental
concern of xenobiotics which is still emerging. Usually, medicine recommended for
flushing are indicated in the medication guide of such drugs.
4.3. European Union (EU) regulations
The new directive for human pharmaceuticals explicitly requires that all members states
should establish collection systems for unused or expired medicines such systems were already
in use in several member countries at the time new legislation went into action in 2004.
However the directive does not regulate how the collected pharmaceuticals should be handled.
Disposal into the sewage system is still the legally accepted route of elimination. However,
incineration at high temperature (12000C) is a preferred alternative to avoid environmental
pollution.
4.4. United States Environmental Protection Agency (EPA) recommendation on disposal of
household pharmaceuticals
Many state and local enforcements agencies, communities and organizations have established
take back events, mail – back and other collection programs to collect old, expired or simply
unwanted prescription and over the counter pharmaceuticals from households. The progress
the safe disposal household pharmaceuticals have become more prevalent throughout
communities in order to reduce the misuse and abuse of drugs and to prevent the practice of
flushing consumer pharmaceuticals which may result in their entry into the environment.
There are laws put in place enforced by the Drug Enforcement Administration’s (DEA) to
protect public health and safety. Many of such drugs are household pharmaceuticals which
are collected through the take-back events. In October 2010, the Secure and Responsible Drug
Disposal Act of 2010 was enacted. The Act and implementing regulations will provide the basic
framework to allow the public who are the ultimate uses to dispose of their unwanted or
expired controlled substance pharmaceuticals in a secure and responsible manner. Currently,
pharmaceuticals collected from ultimate users in a take back event are mostly destroyed by
incineration EPA is currently recommending incineration as the preferred disposal method
for household take back programme. Since it is believed that incineration will address both
environmental and diversion concerns (EPA 2012). It is an accepted fact that excretion of drugs
after human and veterinary therapeutic use dominates the global input of pharmaceuticals
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into the environment. Other sources include effluent discharges from hospitals and manufac‐
turing sites if emissions are not properly treated and controlled. If appropriate preventive
methods are put in place, disposal of unused drugs can be effectively managed. A drug
disposal programme is therefore inevitable and may include guidance for patients, take back
schemes and distinct disposal procedures.
Unlike manufacturing related sources and unused drugs, pharmaceutical residues in the
environment as a consequence of patients drug use are inevitable. The level of effective sewage
treatment in a particular region may reduce the resulting concentrations; but there will still be
some residues remaining. Therefore the challenge to scientists and environmentalists is to
determine the acceptable level that will pose no significant health risk.
4.5. WHO guideline for safe disposal of unwanted pharmaceuticals
The WHO guidelines on safe disposal of unwanted pharmaceuticals stemmed from experien‐
ces of handling large quantities of drugs donated as part of humanitarian assistance during
conflicts and natural disasters. Undoubtedly many of the pharmaceuticals save lives and
alleviate suffering, but some donations given with good intention may not only be utterly
useless but may result in waste and disposal challenges. Pharmaceuticals may arrive past or
near their expiry date, may be inappropriate for the needs, be unrecognizable because they are
labeled in a foreign language or may have been sent in unwanted quantities. Furthermore,
donated pharmaceuticals with a long shelf – life may be mismanaged, particularly in the
confusion during and after armed conflict or natural disasters. Staff and storage space may be
lacking and the pharmaceutical management system in disarray. Smaller quantities of
pharmaceutical waste may accumulate in the absence of emergency situations due to inade‐
quacies in stock management and distribution and to lack of a routine system of disposal. Safe
disposal of these unwanted or expired drugs often creates a major problem. To mitigate these
challenges, the World Health Organization (WHO) has developed a guidelines for safe
disposal of pharmaceutical wastes and unwanted drugs and these include.
a. Disposal methods
i. return to donor or manufacturers
ii. dispatch to landfill
iii. waste immobilization: encapsulation
iv. waste immobilization: inertization
v. dispatch to sewers
vi. Burning in open containers: this can only be used for small quantities to prevent
air pollution due to release of smoke and residues.
vii. Medium temperature incineration
viii. Novel high temperature incineration
ix. Chemical decomposition.
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b. Sorting
Drugs are better managed when sorted into categories e.g. anti-histamines, expired or
unwanted drugs, hazardous or potentially hazardous non-pharmaceutical materials like
aerosol cans and recyclable materials.
c. Recommended disposal methods by sorting category sorting leads to application of
appropriate disposal methods. For example solids, semi solids and powders, liquids,
ampoules, anti-infective drugs, controlled substances, anti-neoplastics, disinfectants and
aerosol canisters are disposed differently
4.6. Environmental ethics
The recent identification of single nucleotide polymorphism (SNPs) and their correlation with
the modulation of enzyme activity in human cases has further crystallized the links between
factors implicated in individual susceptibility and exposure to toxic substances in the envi‐
ronment. The frequently evident opposition between causal interpretations based either on
genetic heritage or an external environmental facts serves to focus attention on the possibility
that the triumph of “constitutionalist” views may reject the more complex and costly primary
prevention measures to deal with pollution. In ethical terms the class between the genetic
susceptibility of certain population groups and the vulnerability of the human “condition”
bound up with our interdependence on the environment requires that we overcome the
prevailing opinion that holds exposure to toxic substances to be normal. The supposed
congenital deficient of sore subjects or disorders linked to age, health condition or lifestyles
fails to recognize that the risks to human health affect every single person without exception.
Environmental pharmacology or eco-pharmacology, though an evolving scientific concept
possesses a great potential to promote “green healthcare”, reduce health costs, protect the
environment and public health. From all indications environmental-drug contamination from
pharmaceutical residues, drug manufacturing, cosmetics, veterinary drugs, and herbicides are
of a global concern that calls for drugs environmental fate profiling. Gleaning a lesson from
the principle of environmental protection which is prevention, it is important to emphasize
prudent drug prescription by physicians. In addition, regulatory agencies should establish
functional ecopharmacovigilance programme. This will not only protect the environment but
will reduce the evolution of antibiotic stains of pathogens and reduce waste of resources on
unused drugs.
4.7. Environmental Risk Assessment (ERA) and environmental classification of drugs
In most developed countries, there are regulatory requirements governing the environmental
risk assessment of pharmaceuticals. In most cases, a new regulatory submission or line
extension has to be accompanied by an ERA which requires environmental fate and effects
tests to be taken (Holm et al 2012). Procedure for ERA involves the generation of a risk quotient;
i.e. the ratio of the predicted environmental concentration (PEC) to the predicted no – effect
concentration (PNEC) ratio (PEC: PNEC). The PEC provides an estimate of maximum
concentration anticipated to occur in the environment resulting from patient use and subse‐
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quent excretion into the waste water systems. Currently, the concept of ecopharmacovigilance
is evolving. This implies environmental protection from pharmaceutical contamination.
Although slightly distinct from pharmacovigilance, which is patient oriented, there is never‐
theless a measure of provision for ecopharmacovigilance within the European Pharmacovigi‐
lance Framework, which includes a reference to the pollution of waters and soils with
pharmaceutical residues and states that “member states should consider measures to monitor
and evaluate the risk of environmental effects including those which may have an impact on public
health”.Furthermore, it should be observed that the general industrial practices include
environmental impact assessment (EIA) therefore, the concept of ecopharmacovigilance which
has drugs, cosmetics and household products as its focus is an additional provision for
environment protection
In Sweden, the industry together with universities and health care sector had developed a
method for environmental risk assessment and environmental classification of drugs. Envi‐
ronmental risk refers to the risk of toxicity to the aquatic environment. It is based on the ratio
between predicted environmental concentration (PEC) and the highest concentration of the
substance that does not have a harmful effect in the environment (PNEC). Environmental
hazard expresses the inherent environmentally damaging characteristics of the substance in
terms of persistence, bioaccumulation and toxicity. The toxicity tests used are usually acute
toxicity of fish, acute toxicity of Daphnia specie and growth inhibition test for algae. Most
medication on the Swedish market are now classified. This gives the health care practitioner
the possibility to make better choices when prescribing medicine (Fent 2006,Daughton and
Ruhoy 2008).
5. Ecopharmacovigilance (EPV)
The term “vigilance” according to the dictionary is the ability to maintain attention and
alertness over a prolonged period of time. Traditionally, the focus of pharmacovigilance has
been directed towards detecting, monitoring collecting, assessing and evaluating data
regarding the human hazard posed by medicine, with the primary objective to reduce the
occurrence of adverse drug reaction to the patients. While pharmacovigilance has a clinical
focus, ecopharmacovigilance has an environmental focus. It will therefore be erroneous to
attempt to group the two together. For example, the role of pharmacovigilance commences
from post marketing surveillance while ecopharmacovigilance commences from the point of
production to the point of disposal. However there is a little provision for environmental
protection by those responsible for pharmaco vigilance from unintentional contact with the
active ingredient in pharmaceuticals. Therefore as the practice of ecopharmacovigilance
evolves, for practical purposes it will be expedient to concede the responsibility to the
environmental health or public health department. In an attempt to rightly define the proce‐
dure for ecopharmacovigilance, it is important to examine the procedural framework for
pharmacovigilance. This include (a) Post marketing surveillance and other methods of adverse
drug reactive (ADR) monitoring such as voluntary reporting by doctors (b) dissemination of
ADR data through “drug alerts” or “medical alerts” adversaries sent to doctors by pharma‐
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ceuticals and regulatory agencies such as FDA in the USA, committee on safety of medicines
in UK and NAFDAC in Nigeria. (c) Changes in the labeling of medicine indicating restrictions
in use or statutory warnings, precautions or even withdrawal of the drug. (Cuklev et al 2012,
Fick 2010,Holn et al 2008 )
From all indications while pharmacovigilance is patient oriented, ecopharmacovigilance is
environment and public health oriented. However, it is rational to have a cooperation between
the two. Thus, ecopharmacovigilance can be defined as the “science and activities relating to
the safe discharge of effluents from drug manufacturing pants, safe handling and disposal of
drugs and syringes in the hospital and sewage plants. While pharmacovigilance falls within
the purview of pharmacists, doctors and nurses who deals with administration of drugs,
ecopharmacovigilance entails the dedication of environmental health officers, public health
engineers, veterinary physicians and agriculturists. However, those to be charged with
environmental monitoring of drugs should be knowledgeable in same. In ecopharmacovigi‐
lance, there are some practical measures that can be taken to assess environmental risks across
the product life-cycle; particularly after the launch of a new drug, to ensure that risk assessment
and scientific understanding of pharmaceuticals in the environment remain scientifically and
ecologically relevant (Kummerer and Velo 2006,Rahman et al 2007)
These measures include:
a. Ensuring that the effluent from production source are treated and properly disposed of.
b. Tracking environmental risks after launch of the product. If not locally manufactured, via
literature monitoring for emerging data on exposure and effects.
c. Using environmental risks management plans, (ERMPs) as a centralized resource to assess
and manage the risks of a drug throughout its life cycle.
d. Further research, testing or monitoring in the environment when a risk is identified.
e. Keeping a global EPV perspective
f. Increasing transparency and availability of environmental data for medicinal products.
These measures could help to ensure that any significant environmental issues associated with
pharmaceuticals in the environment (PIE) are identified in a timely way and can be managed
appropriately (Holn et al 2008).Thus pharmecovigilance should employ a wide spectrum of
means to minimize the ecological footprint of medications as well as the possibility of their
causing harm to humans and domestic animals, not just by way of intended use, but also by
their unintended use as well as cessation of use. Many drugs have double lives. Once the active
pharmaceutical ingredients (API) in administered medications have completed their intended
purposes in therapy, disease prevention diagnosis or cosmetics, they can take on another lives
in the environment. APIs from a large and diverse spectrum of pharmaceuticals can enter the
environment as trace contaminants especially in waters, at individual concentrates generally
less than a part per billion (mg/l) but sometimes more. The predominant route by which API’s
gain entry into the environment is via the discharge of treated and untreated sewage contam‐
inate with PAI simply as a result of medications used for the purposes for which they were
Pharmacology and Therapeutics164
designed. Residues of APIs from drugs that are administered parenterally (e.g. via injection
and infusion) and entereally (e.g via ingestion) are often excreted in faeces and urine and
topically applied medications can be washed from skin during bathing. For most APIs, the
fraction of unchanged, parent API transferred to the environment is altered as a result of
metabolic activities in the body or transformation within a sewage treatment facility such as
microbial degradation, for some APIs, only a small percentage of the total amount used is ever
transported to the environment. For others, this percentage can approach 100%.The secondary
route of transfer of API to the environment is from the purposed, direct disposal of left over
or unwanted medications to sewers as trash (Daughton and Ruhoy 2008).
In ecopharmacovigilance, pharmacovigilance and environmental protection are intimately
tied just as are human health and ecological integrity (Daughton 2003a). The importance of
ecopharmacovigilance cannot be over emphasized and if properly applied, there will be
reduction in ecological exposure to drug contaminants and reduction of drug residues though
at low levels making their way into our food and drinking water supplies, thereby further
reducing human exposure. The ultimate goal of ecopharmaco vigilance should be the design
and implementation of changes in the aspects of the drug distribution/consumption chain in
order to minimize or eliminate the generation of left over medications so that disposal is not
needed to begin with. Ecopharmacovigilance has the potential to influence the re-designing
of the healthcare system so that only the most efficacious medications are presented in minimal
doses and dispersed in quantities and for durations to ensure their full consumption. The ideal
outcome would be the absence of left over drugs which require disposal. EPV also promotes
the concept of “greener” healthcare system which not only protects the environment but ensure
more official utilization of healthcare resources, reduced healthcare costs, improved healthcare
outcome and reduced incidence of purposeful drug abuse and accidental poisonings from
diversion of stock piled drugs.
6. Discussion
Drugs and house hold products are part of man’s needs for various purposes. Drugs are
prescribed for various medical conditions and cosmetics and house hold products are con‐
sumables of daily need. However, there is a growing concern among scientists and environ‐
mentalists on the impact of drug contaminants on the environment. This phenomenon is not
limited to any region of the world but global. In many countries, low levels of medicines have
been detected in sewage treatment plant (STP), effluents, surface water, ground water and
drinking water. Effects of some drugs have been investigated in aquatic ecosystems and
different species of the aquatic environment are known to be affected by disposed drugs when
present.
The dramatic decline in vulture population in Asia which was linked to the use of diclofenac
to treat cattle is a classical case of the importance of ecopharmacology. An alarming decline in
the number of vultures poses the threat of outbreak of epidemics in parts of Asia due to
potential increase in the number of decaying carcasses as a result of this. The three species of
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Asia vultures viz Asian white-backed vultures, (Gyps bengalensis) Indian vultures (Gyps
indicus) and slender-billed vultures (Gyps tenuirostris) are listed as critically endangered by the
International Union of Conservation of Nature (IUCN) based in Switzerland. Furthermore, the
decline in the vulture population has threatened the tradition of “Parsis”; a sect of the
Zoroastians who traditionally expose human corpses to vultures for disposal. As a sequelae
in Mumbia, India, it had been reported that Parsis have stopped leaving human corpses in the
“Tower of Silence” because the vultures that once quickly consumed the carcasses are
vanishing (Houston 1990).
There have been specific cases of intersex fish in European rivers. The fact that traces of
different drugs and personal care products including steroids and insect repellant have been
detected in the American waters and the fact that traces of cocaine have been detected in River
Thames in London underscores the global dimension of environmental drugs contamination.
In India, different studies have shown that effluent from waste water treatment plant serving
several pharmaceutical companies contain residues of many drugs, particularly antibiotics.
However, it is generally accepted that the major sources of release of drugs to the ecosystem
is from treated and untreated sewage end products due to human consumption and disposal
of drugs. An important factor that promotes the release of pharmaceutical and house products
into the environment is decaying infrastructure whereby aging sewage pipes are cause leaks
of effluents into the environment.
Perhaps another area of neglect currently in ecopharmacology is the potential effect of herbal
preparations. Herbal drugs have pharmacological properties which are likely to be ignored
with respect to their environmental impact due to the assumption that plants are generally
natural entities and therefore environmentally friendly. There is therefore the necessity for
more studies of environmental impact of herbarium processes. In the same respect the effect
of marijuana” probably the most commonly consumed narcotic worldwide on the ecosystem
is likely to be dramatic. For example, it was observed that hay contaminated with the Chinese
herb Aristolochia specie caused renal failure in horses (Grollman 2013). In addition, Parsley;
another commonly used herbal preparation was said to have the negative attribute of absorb‐
ing toxic metals from the environment and therefore, its cultivation near waste water or using
waste water for its irrigation is discouraged (Awe and Banjoko 2012). It is also important to
note that preventing environmental drug contamination will protect the very important
biofilm of the ecosystem and of the sewage system for proper functioning. The basic principle
of environmental protection is prevention of environmental pollution, minimizing unavoid‐
able emissions and remediating any existing damage. With reference to environmental
pharmacology, it is therefore expedient to reduce as much as possible the use and circulation
of drugs and establish a program or coordinated disposal of unused drugs. For example, there
could be a take-back scheme whereby unused drugs are returned to the source of dispensing
for proper disposal. There should be more prudent prescribing of drugs and patient use.
Private stock piling of drugs and improper storage should be discouraged and the established
drug disposal route should be monitored periodically. The very important impact of unsafe
disposal of drugs is the potential of promoting the evolution of antimicrobial resistant
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pathogens. This has a significant impact on clinical practice, public health, health economics
and even ecopharmacology.
7. Conclusion and recommendations
The scope of human exposure to pharmaceuticals and personal care products from the
environment is a complex function of many factors. These factors include the concentrations,
types and distribution of pharmaceuticals in the environment, the pharmacokinetics is of each
drug, the structural transformation of the chemical compounds either through metabolism or
natural degradation processes and the potential bioaccumulation of the drugs. Furthermore,
the full effects of mixtures of low concentrations of different PPCPs is also unknown there is
therefore concern about the potential they have for harm because they may act unpredictably
when mixed with other chemicals from the environment or concentration in the food chain.
In addition,, some PPCPS are active at very low concentrations, and are often released
continuously in large or widespread quantities. Proper destruction of pharmaceutical residues
should yield rest products without any environmental formation of such new products.
Incineration at a high temperature greater then 1000 degrees Celsius is considered to fulfill the
requirements, but even following such incineration residual ashes from the incineration should
be properly taken care of. Pharmaceuticals used in veterinary medicine or as additives to
animal food, pose a different problem, since they are excreted into soil or possibly open surface
waters. It is well known that such excretions may affect terrestrial organisms directly, leading
to extinction of exposed species e.g. dung beetles. Futhermore, lipid – soluble pharma residues
from veterinary use may bind strongly to soil particles, with little tendency to leak out to
ground water or to local surface waters. In addition more water – soluble residues may be
washed out with rain or melting snow and reach both ground water and surface water streams.
8. Recommendations
• Contamination of drinking water mist be avoided and landfills must be sited and con‐
structed in a way that minimizes the possibility of leachate entering an aquifer, surface water
or drinking water system.
• Non- biodegradable drugs, antibiotics, anti-neoplastics and disinfectants should not be
disposed into the sewage system as they may kill bacteria necessary for the treatment of
sewage. Anti-neoplastics should not be flushed into water courses as they may damage
aquatic life or contaminate drinking water. Similarly, large quantities of disinfectants should
not be discharged into sewerage system or water course but can be introduced if well
diluted.
• Burning pharmaceuticals at low temperature or in open containers results in release of toxic
pollutants into the air. Ideally this should be avoided.
Environmental Pharmacology – An Overview
http://dx.doi.org/10.5772/57473
167
• Inefficient and insecure sorting and disposal may allow drugs beyond their expiry date to
be diverted for resale to the general public. In some countries, scavenging in unprotected
insecure landfills is a hazard.
• In the absence of suitable disposal sites and qualified personnel to supervise disposal,
unwanted pharmaceuticals present no risk provided they are securely stored in dry
conditions. If stored in their original packing, there is a risk of diversion and to avoid this,
they are best stored in drins with the pharmaceuticals immobilized.
• Effective environmental detection methods have to be developed and global detection
strategy applied to map the current global situation.
• There are currently no test methods to assess whether negative effects may occur after long
term environmental diffuse exposure in humans, during the vulnerable periods of devel‐
opment, on aquatic micro organisms or how it may affect other animals. Therefore the pre-
cautionary principle must be guiding.
• Concentrations in surface water alone are not sufficient to assess the risk of negative
environmental effects of these synthetic chemicals. Consideration must be taken to bio-
accumulation in fish and other aquatic foods consumed by humans, as well as to additive
and synergistic effects between pharmaceuticals and other chemicals in the contaminated
wate
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